North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 26 of 26
Details
UPD
sitematrix Changed from 0 to
14/03/2024 15:24:52
(DavidS )
UPD
FurtherInformation Changed from
300mg/30ml solution for infusion
Approved treating atypical haemolytic uraemic syndrome in adults and children in line with NICE
Paroxysmal nocturnal haemoglobinuria treatmen
14/03/2024 15:24:52
(DavidS )
UPD
Eculizumab amended
14/03/2024 15:24:52
(DavidS )
UPD
sitematrix Changed from 0 to
14/03/2024 15:23:34
(DavidS )
UPD
FurtherInformation Changed from
300mg/30ml solution for infusion
Approved treating atypical haemolytic uraemic syndrome in adults and children in line with NICE
14/03/2024 15:23:33
(DavidS )
UPD
Eculizumab amended formatting
14/03/2024 15:23:33
(DavidS )
LDL
Link Added : NICE TA647: Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal) : https://www.nice.org.uk/guidance/TA647
30/06/2023 15:27:35
(rpaylor )
LDL
Link Added : NICE TA636: Eculizumab for treating refractory myasthenia gravis (terminated appraisal) : https://www.nice.org.uk/guidance/ta636
30/06/2023 15:27:12
(rpaylor )
UPD
sitematrix Changed from 0 to
26/04/2022 13:23:54
(DavidS )
UPD
FurtherInformation Changed from
300mg/30ml solution for infusion
Approved treating atypical haemolytic uraemic syndrome in adults and children in line with NICE
26/04/2022 13:23:54
(DavidS )
UPD
Eculizumab updated formatting
26/04/2022 13:23:54
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 13:23:38
(DavidS )
UPD
FurtherInformation Changed from
300mg/30ml solution for infusion
Approved treating atypical haemolytic uraemic syndrome in adults and children in line with NICE
to
300mg/30ml solution for infusion
A
26/04/2022 13:23:38
(DavidS )
UPD
Eculizumab updated
26/04/2022 13:23:38
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 13:11:17
(DavidS )
UPD
FurtherInformation Changed from
For use in accordance with NICE and NHS England commissioning policies.
to
300mg/30ml solution for infusion
Approved treating atypical haemolytic uraemic syndrome in adults and c
26/04/2022 13:11:17
(DavidS )
UPD
Eculizumab updated
26/04/2022 13:11:17
(DavidS )
UPD
Eculizumab Published from Draft Mode
26/04/2017 10:25:57
(LoweryM )
UPD
Eculizumab updated
26/04/2017 10:18:53
(LoweryM )
UPD
Eculizumab Additional Clinical Commissioning Policy from NHS England
21/04/2017 10:38:34
(DavidS )
LDL
Link Added : Clinical Commissioning Policy: Eculizumab in the treatment of recurrence of C3 glomerulopathy postkidney transplant (all ages) Reference: NHS England: 16054/P : https://www.england.nhs.uk/wp-content/uploads/2017/02/clin-comms-policy-16054p.pd
21/04/2017 10:37:59
(DavidS )
UPD
Eculizumab b
01/02/2017 14:01:01
(WhitehallJ )
LDL
Link Added : NICE HST 1 - Eculizumab for treating atypical haemolytic uraemic syndrome : https://www.nice.org.uk/guidance/hst1
23/01/2017 14:56:38
(DavidS )
UPD
Eculizumab b
23/01/2017 14:56:05
(DavidS )
UPD
Eculizumab b
23/01/2017 14:55:47
(DavidS )
UPD
Eculizumab Build
29/11/2016 10:35:39
(ClarkH )